TransMedics Group, Inc. (TMDX)

31.29 -0.86 (-2.67%) At close: 04:00PM EDT

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900
https://www.transmedics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 148

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Waleed H. Hassanein M.D.	Founder, Pres, MD, CEO & Director	992.42k	7.62M	1968
Mr. Stephen Gordon	CFO. Treasurer & Sec.	529.32k	1.79M	1968
Dr. Tamer I. Khayal M.D.	Chief Commercial Officer	551.37k	1.67M	1969
Ms. Miriam C. Provost Ph.D.	VP of Global Regulatory Affairs	439.19k	158.85k	N/A
Ms. Laura Damme	VP of Clinical Affairs	337.31k	N/A	N/A
Mr. John F. Carey	VP of Operations	N/A	N/A	1965
Mr. Ike Okonkwo	VP of Fin. & Accounting	N/A	N/A	1971
Mr. Mark Anderson	Sr. Director of Technology Devel.	N/A	N/A	N/A
Ms. Susan Goodman	VP of HR	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Corporate Governance

TransMedics Group, Inc.’s ISS Governance QualityScore as of June 1, 2022 is 5. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 3; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.